D J Kerr|W D Alexander - JoVE Visualize

Showing results (201-210 of 219) with videos related to

Pageof 22

Sort By:

International Journal of Cancer|June 8, 2000

Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductaseS J Weedon, N K Green, I A McNeish, et al.

Acta Endocrinologica. Supplementum|January 1, 1987

Effects of high and low doses of methimazole in patients with Graves' thyrotoxicosisG Benker, D Reinwein, H Creutzig, et al.

Biochemical Pharmacology|March 1, 1984

Peroxidase activity in relation to iodide, 17 beta-oestradiol and thioureylene drug uptake in human polymorphoneutrophilsM M Ferguson, W D Alexander, J M Connell, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpointsD R Ferry, M Deakin, J Baddeley, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001

Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954G Chung-Faye, D Palmer, D Anderson, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 1999

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamineP J Julyan, L W Seymour, D R Ferry, et al.

British Journal of Cancer|August 11, 2012

The TERT variant rs2736100 is associated with colorectal cancer riskB Kinnersley, G Migliorini, P Broderick, et al.

British Journal of Cancer|December 1, 1996

Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solutionD J Kerr, A M Young, J P Neoptolemos, et al.

Blood|July 9, 1999

Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's diseaseP G Murray, L J Billingham, H T Hassan, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007

A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecanR S Midgley, D J Kerr, K T Flaherty, et al.

Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:

Pageof 22

International Journal of Cancer|June 8, 2000

Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductaseS J Weedon, N K Green, I A McNeish, et al.

Acta Endocrinologica. Supplementum|January 1, 1987

Effects of high and low doses of methimazole in patients with Graves' thyrotoxicosisG Benker, D Reinwein, H Creutzig, et al.

Biochemical Pharmacology|March 1, 1984

Peroxidase activity in relation to iodide, 17 beta-oestradiol and thioureylene drug uptake in human polymorphoneutrophilsM M Ferguson, W D Alexander, J M Connell, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpointsD R Ferry, M Deakin, J Baddeley, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001

Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954G Chung-Faye, D Palmer, D Anderson, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 1999

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamineP J Julyan, L W Seymour, D R Ferry, et al.

British Journal of Cancer|August 11, 2012

The TERT variant rs2736100 is associated with colorectal cancer riskB Kinnersley, G Migliorini, P Broderick, et al.

British Journal of Cancer|December 1, 1996

Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solutionD J Kerr, A M Young, J P Neoptolemos, et al.

Blood|July 9, 1999

Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's diseaseP G Murray, L J Billingham, H T Hassan, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007

A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecanR S Midgley, D J Kerr, K T Flaherty, et al.

Pageof 22